Suchergebnisse - "Wirchnianski, Ariel S."

PubPharm (44)

11

Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference

enthalten in: medRxiv : the preprint server for health sciences | 2022

von Fels, J. | Khan, S. | Forster, R. | +21

UpdateIn: Cold Spring Harb Mol Case Stud. 2022 Jul 13;:. - PMID 35831070

12

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients : A Randomized Clinical Trial

enthalten in: JAMA internal medicine | 2022

von Ortigoza, M. | Yoon, H. | Goldfeld, K. | +192

13

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes

enthalten in: PLoS computational biology | 2022

von Lasso, G. | Khan, S. | Allen, S. | +29

14

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

enthalten in: mBio | 2021

von Haslwanter, D. | Dieterle, M. | Wec, A. | +27

15

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative Immunoglobulin G Assays : The Value of Numeric Reporting

enthalten in: Archives of pathology & laboratory medicine | 2021

von Forest, S. | Orner, E. | Goldstein, D. | +17

16

Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever

enthalten in: Cell | 2021

von Fels, J. | Maurer, D. | Herbert, A. | +26

17

Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts

enthalten in: mSphere | 2021

von Bortz, R. | Florez, C. | Laudermilch, E. | +38

UpdateOf: medRxiv. 2020 Sep 11;:. - PMID 32935116

18

Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization

enthalten in: Journal of virology | 2021

von Wang, Y. | Howell, K. | Brannan, J. | +15

19

Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC

enthalten in: JCI insight | 2021

von Yoon, H. | Bartash, R. | Gendlina, I. | +52

UpdateOf: medRxiv. 2020 Dec 04;:. - PMID 33300012

20

Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity

enthalten in: Frontiers in immunology | 2021

von Wirchnianski, A. | Wec, A. | Nyakatura, E. | +9